Protein Symbol | Approved Name | Docking Scores |
Similarity Score |
Best Match | ||
---|---|---|---|---|---|---|
Model 1 | Model 2 | Model 3 | ||||
5HT1B_HUMAN | 5-hydroxytryptamine receptor 1B | -8.95 | -9.22 | -8.65 | 62.86% | CHEMBL263700 |
5HT2A_HUMAN | 5-hydroxytryptamine receptor 2A | -9.01 | -8.20 | N/A | 53.79% | CHEMBL267615 |
5HT2B_HUMAN | 5-hydroxytryptamine receptor 2B | -9.03 | -8.92 | -9.29 | 49.69% | CHEMBL221811 |
5HT2C_HUMAN | 5-hydroxytryptamine receptor 2C | -9.36 | -8.53 | N/A | 59.49% | CHEMBL2260565 |
AA1R_HUMAN | adenosine A1 receptor | -9.21 | -8.81 | -9.96 | 50.67% | CHEMBL2435536 |
AA2AR_HUMAN | adenosine A2a receptor | -9.37 | -9.57 | -9.92 | 42.86% | CHEMBL3677906 |
ACES_HUMAN | acetylcholinesterase (Cartwright blood group) | -9.64 | -10.23 | -9.76 | 54.07% | CHEMBL4102333 |
ACE_HUMAN | angiotensin I converting enzyme | -8.44 | -8.58 | -7.49 | 46.11% | CHEMBL305388 |
ACHA9_HUMAN | cholinergic receptor nicotinic alpha 9 subunit | -7.17 | N/A | N/A | 33.80% | CHEMBL386114 |
ACHB2_HUMAN | cholinergic receptor nicotinic beta 2 subunit | -4.17 | -2.49 | -2.93 | N/A | N/A |
ACM1_HUMAN | cholinergic receptor muscarinic 1 | -7.97 | 1.86 | N/A | 50.00% | CHEMBL3126661 |
ACM4_HUMAN | cholinergic receptor muscarinic 4 | -8.68 | -9.94 | N/A | 43.75% | CHEMBL104332 |
ADRB2_HUMAN | adrenoceptor beta 2 | -8.76 | -9.08 | -8.71 | 49.69% | CHEMBL444553 |
AGTR2_HUMAN | angiotensin II receptor type 2 | -8.79 | -9.13 | -8.95 | 49.25% | CHEMBL40381 |
ALDR_HUMAN | aldo-keto reductase family 1 member B | -8.98 | -8.72 | -8.53 | 48.50% | CHEMBL1944855 |
AMPN_HUMAN | alanyl aminopeptidase, membrane | -8.25 | -9.08 | -8.48 | 44.66% | CHEMBL1077591 |
AOFA_HUMAN | monoamine oxidase A | -9.57 | -10.12 | -10.14 | 46.01% | CHEMBL155350 |
AOFB_HUMAN | monoamine oxidase B | -9.99 | -10.20 | -10.17 | 42.08% | CHEMBL2333929 |
BACE1_HUMAN | beta-secretase 1 | -7.31 | -7.70 | -9.12 | 42.36% | CHEMBL556087 |
CAH2_HUMAN | carbonic anhydrase 2 | -7.55 | -8.64 | -8.92 | 49.69% | CHEMBL2335176 |
CASP1_HUMAN | caspase 1 | -6.27 | -6.91 | -6.82 | 50.60% | CHEMBL1221644 |
CDK5_HUMAN | cyclin dependent kinase 5 | -8.26 | -9.52 | -9.53 | 48.52% | CHEMBL1970352 |
CHLE_HUMAN | butyrylcholinesterase | -9.17 | -9.33 | -9.45 | 51.85% | CHEMBL3628186 |
CNR1_HUMAN | cannabinoid receptor 1 | -7.56 | -9.31 | -10.10 | 56.76% | CHEMBL2206858 |
CNR2_HUMAN | cannabinoid receptor 2 | -9.23 | -9.20 | N/A | 92.70% | CHEMBL72324 |
COLI_HUMAN | proopiomelanocortin | -8.57 | -8.55 | -8.17 | N/A | N/A |
COMT_HUMAN | catechol-O-methyltransferase | -6.23 | -6.16 | -7.30 | 40.72% | CHEMBL3425731 |
CRP_HUMAN | C-reactive protein | -6.41 | -5.84 | N/A | N/A | N/A |
CXCR1_HUMAN | C-X-C motif chemokine receptor 1 | -1.27 | N/A | N/A | 28.57% | CHEMBL518857 |
CXCR4_HUMAN | C-X-C motif chemokine receptor 4 | -8.31 | -6.94 | -7.89 | 39.18% | CHEMBL1644072 |
DRD2_HUMAN | dopamine receptor D2 | -8.01 | N/A | N/A | 53.99% | CHEMBL245764 |
DRD3_HUMAN | dopamine receptor D3 | -8.18 | N/A | N/A | 62.43% | CHEMBL461571 |
DRD4_HUMAN | dopamine receptor D4 | -8.83 | -8.63 | N/A | 43.64% | CHEMBL460854 |
EDN1_HUMAN | endothelin 1 | -7.02 | N/A | N/A | N/A | N/A |
ESR1_HUMAN | estrogen receptor 1 | -6.88 | -8.02 | -8.01 | 62.90% | CHEMBL396118 |
FABP5_HUMAN | fatty acid binding protein 5 | -9.13 | -6.06 | -6.31 | 35.86% | CHEMBL3950316 |
FYN_HUMAN | FYN proto-oncogene, Src family tyrosine kinase | -8.57 | N/A | N/A | 48.52% | CHEMBL1970352 |
GLRA3_HUMAN | glycine receptor alpha 3 | -8.55 | -8.22 | -8.18 | 27.27% | CHEMBL4070615 |
GLRA3_HUMAN | glycine receptor alpha 3 | -9.21 | N/A | N/A | 27.27% | CHEMBL4070615 |
GRM5_HUMAN | glutamate metabotropic receptor 5 | -5.57 | -5.30 | -5.48 | 44.03% | CHEMBL377706 |
HPGDS_HUMAN | hematopoietic prostaglandin D synthase | -7.72 | -6.64 | -6.63 | 34.74% | CHEMBL3425948 |
HRH1_HUMAN | histamine receptor H1 | -5.94 | N/A | N/A | 50.58% | CHEMBL589389 |
HYES_HUMAN | epoxide hydrolase 2 | -8.11 | -8.74 | -8.18 | 40.59% | CHEMBL3114610 |
IKKB_HUMAN | inhibitor of nuclear factor kappa B kinase subunit beta | -8.29 | N/A | N/A | 38.98% | CHEMBL1761510 |
MDR1_HUMAN | ATP binding cassette subfamily B member 1 | -8.27 | -8.39 | N/A | 47.22% | CHEMBL3354882 |
MIF_HUMAN | macrophage migration inhibitory factor | -6.99 | -6.75 | -6.24 | 32.24% | CHEMBL1289631 |
MK01_HUMAN | mitogen-activated protein kinase 1 | -8.20 | -8.47 | -7.51 | 42.54% | CHEMBL2005528 |
MK03_HUMAN | mitogen-activated protein kinase 3 | -8.69 | -9.01 | -7.86 | 41.85% | CHEMBL3798015 |
MTOR_HUMAN | mechanistic target of rapamycin kinase | -9.04 | -9.56 | -8.97 | 40.38% | CHEMBL1089653 |
NEP_HUMAN | membrane metalloendopeptidase | -7.48 | -7.58 | -8.41 | 46.11% | CHEMBL305388 |
NK1R_HUMAN | tachykinin receptor 1 | -8.65 | -8.88 | -8.59 | 52.55% | CHEMBL21787 |
NMDE1_HUMAN | glutamate ionotropic receptor NMDA type subunit 2A | -9.03 | -9.52 | -7.00 | 21.43% | CHEMBL284237 |
NMDE2_HUMAN | glutamate ionotropic receptor NMDA type subunit 2B | -9.38 | -9.35 | -9.60 | 43.23% | CHEMBL444384 |
NMDZ1_HUMAN | glutamate ionotropic receptor NMDA type subunit 1 | -8.83 | -9.39 | -7.00 | 38.67% | CHEMBL163916 |
NOS1_HUMAN | nitric oxide synthase 1 | -8.92 | -8.92 | -8.81 | 36.41% | CHEMBL474637 |
NOS2_HUMAN | nitric oxide synthase 2 | -8.01 | -9.02 | -7.86 | 35.84% | CHEMBL1221659 |
NTRK1_HUMAN | neurotrophic receptor tyrosine kinase 1 | -9.46 | -9.57 | -9.61 | 51.24% | CHEMBL3661550 |
OPRD_HUMAN | opioid receptor delta 1 | -8.07 | -6.86 | -7.40 | 46.41% | CHEMBL389072 |
OPRK_HUMAN | opioid receptor kappa 1 | -9.39 | -8.97 | -7.95 | 50.33% | CHEMBL212574 |
OPRM_MOUSE | Mu-type opioid receptor | -8.50 | -8.12 | N/A | 45.83% | CHEMBL2147917 |
OPRX_HUMAN | opioid related nociceptin receptor 1 | -7.49 | -7.25 | -7.46 | 50.33% | CHEMBL212574 |
P2RX3_HUMAN | purinergic receptor P2X 3 | -6.23 | -6.00 | -6.19 | 46.19% | CHEMBL3978296 |
P2Y12_HUMAN | purinergic receptor P2Y12 | -8.52 | -7.16 | -7.66 | 42.73% | CHEMBL3325895 |
PAR1_HUMAN | coagulation factor II thrombin receptor | -6.50 | N/A | N/A | 40.36% | CHEMBL7610 |
PDE4B_HUMAN | phosphodiesterase 4B | -9.30 | -9.28 | -9.17 | 43.48% | CHEMBL290191 |
PDE5A_HUMAN | phosphodiesterase 5A | -9.11 | -9.95 | -9.38 | 46.00% | CHEMBL245850 |
PERM_HUMAN | myeloperoxidase | -8.42 | -8.77 | -8.79 | 38.99% | CHEMBL2347029 |
PGH1_SHEEP | Prostaglandin G/H synthase 1 | -6.52 | -7.10 | -8.65 | 100.00% | CHEMBL6 |
PGH2_HUMAN | prostaglandin-endoperoxide synthase 2 | -4.74 | -5.42 | -7.64 | 100.00% | CHEMBL6 |
PPAP_HUMAN | acid phosphatase 3 | -8.76 | N/A | N/A | 25.44% | CHEMBL507996 |
PPARG_HUMAN | peroxisome proliferator activated receptor gamma | -8.28 | -8.72 | -8.41 | 80.00% | CHEMBL360762 |
PRGR_HUMAN | progesterone receptor | -5.84 | -6.69 | -8.93 | 45.21% | CHEMBL3622996 |
PTGES_HUMAN | prostaglandin E synthase | -6.55 | N/A | N/A | 53.76% | CHEMBL360114 |
SC6A4_HUMAN | solute carrier family 6 member 4 | -9.36 | -8.74 | -9.19 | 62.43% | CHEMBL461571 |
SCN9A_HUMAN | sodium voltage-gated channel alpha subunit 9 | -7.34 | N/A | N/A | 59.52% | CHEMBL3941974 |
TLR4_HUMAN | toll like receptor 4 | -7.49 | -7.73 | -7.18 | 38.66% | CHEMBL1223751 |
TNFA_HUMAN | tumor necrosis factor | -7.50 | N/A | N/A | 46.88% | CHEMBL1392142 |
TRBM_HUMAN | thrombomodulin | -6.75 | -6.81 | N/A | N/A | N/A |
TRPM4_HUMAN | transient receptor potential cation channel subfamily M member 4 | -7.51 | -6.53 | N/A | N/A | N/A |
TRPM8_FICAL | Uncharacterized protein | -9.14 | N/A | N/A | N/A | N/A |
TRPV1_RAT | Transient receptor potential cation channel subfamily V member 1 | -7.32 | N/A | N/A | 50.53% | CHEMBL438345 |
TRPV2_RABIT | Transient receptor potential cation channel subfamily V member 2 | -8.17 | -7.86 | N/A | N/A | N/A |
TRPV3_HUMAN | transient receptor potential cation channel subfamily V member 3 | -6.80 | -6.76 | N/A | 35.94% | CHEMBL3664218 |
TRXR1_HUMAN | thioredoxin reductase 1 | -8.00 | -7.70 | -6.46 | N/A | N/A |
TRY1_HUMAN | serine protease 1 | -6.06 | N/A | N/A | 52.02% | CHEMBL422722 |